Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden a nationwide study
We conducted a nationwide, registry-based study to investigate the importance of 34 potential risk factors for coronavirus disease 2019 (COVID-19) diagnosis, hospitalization (with or without intensive care unit [ICU] admission), and subsequent all-cause mortality. The study population comprised all...
Saved in:
| Published in: | European journal of epidemiology Vol. 36; no. 3; pp. 287 - 298 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Dordrecht
Springer Science + Business Media
01.03.2021
Springer Netherlands Springer Nature B.V |
| Subjects: | |
| ISSN: | 0393-2990, 1573-7284, 1573-7284 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | We conducted a nationwide, registry-based study to investigate the importance of 34 potential risk factors for coronavirus disease 2019 (COVID-19) diagnosis, hospitalization (with or without intensive care unit [ICU] admission), and subsequent all-cause mortality. The study population comprised all COVID-19 cases confirmed in Sweden by mid-September 2020 (68,575 non-hospitalized, 2494 ICU hospitalized, and 13,589 non-ICU hospitalized) and 434,081 randomly sampled generalpopulation controls. Older age was the strongest risk factor for hospitalization, although the odds of ICU hospitalization decreased after 60–69 years and, after controlling for other risk factors, the odds of non-ICU hospitalization showed no trend after 40–49 years. Residence in a long-term care facility was associated with non-ICU hospitalization. Male sex and the presence of at least one investigated comorbidity or prescription medication were associated with both ICU and non-ICU hospitalization. Three comorbidities associated with both ICU and non-ICU hospitalization were asthma, hypertension, and Down syndrome. History of cancer was not associated with COVID-19 hospitalization, but cancer in the past year was associated with non-ICU hospitalization, after controlling for other risk factors. Cardiovascular disease was weakly associated with non-ICU hospitalization for COVID-19, but not with ICU hospitalization, after adjustment for other risk factors. Excess mortality was observed in both hospitalized and non-hospitalized COVID-19 cases. These results confirm that severe COVID-19 is related to age, sex, and comorbidity in general. The study provides new evidence that hypertension, asthma, Down syndrome, and residence in a long-term care facility are associated with severe COVID-19. |
|---|---|
| AbstractList | We conducted a nationwide, registry-based study to investigate the importance of 34 potential risk factors for coronavirus disease 2019 (COVID-19) diagnosis, hospitalization (with or without intensive care unit [ICU] admission), and subsequent all-cause mortality. The study population comprised all COVID-19 cases confirmed in Sweden by mid-September 2020 (68,575 non-hospitalized, 2494 ICU hospitalized, and 13,589 non-ICU hospitalized) and 434,081 randomly sampled general-population controls. Older age was the strongest risk factor for hospitalization, although the odds of ICU hospitalization decreased after 60–69 years and, after controlling for other risk factors, the odds of non-ICU hospitalization showed no trend after 40–49 years. Residence in a long-term care facility was associated with non-ICU hospitalization. Male sex and the presence of at least one investigated comorbidity or prescription medication were associated with both ICU and non-ICU hospitalization. Three comorbidities associated with both ICU and non-ICU hospitalization were asthma, hypertension, and Down syndrome. History of cancer was not associated with COVID-19 hospitalization, but cancer in the past year was associated with non-ICU hospitalization, after controlling for other risk factors. Cardiovascular disease was weakly associated with non-ICU hospitalization for COVID-19, but not with ICU hospitalization, after adjustment for other risk factors. Excess mortality was observed in both hospitalized and non-hospitalized COVID-19 cases. These results confirm that severe COVID-19 is related to age, sex, and comorbidity in general. The study provides new evidence that hypertension, asthma, Down syndrome, and residence in a long-term care facility are associated with severe COVID-19. We conducted a nationwide, registry-based study to investigate the importance of 34 potential risk factors for coronavirus disease 2019 (COVID-19) diagnosis, hospitalization (with or without intensive care unit [ICU] admission), and subsequent all-cause mortality. The study population comprised all COVID-19 cases confirmed in Sweden by mid-September 2020 (68,575 non-hospitalized, 2494 ICU hospitalized, and 13,589 non-ICU hospitalized) and 434,081 randomly sampled general-population controls. Older age was the strongest risk factor for hospitalization, although the odds of ICU hospitalization decreased after 60-69 years and, after controlling for other risk factors, the odds of non-ICU hospitalization showed no trend after 40-49 years. Residence in a long-term care facility was associated with non-ICU hospitalization. Male sex and the presence of at least one investigated comorbidity or prescription medication were associated with both ICU and non-ICU hospitalization. Three comorbidities associated with both ICU and non-ICU hospitalization were asthma, hypertension, and Down syndrome. History of cancer was not associated with COVID-19 hospitalization, but cancer in the past year was associated with non-ICU hospitalization, after controlling for other risk factors. Cardiovascular disease was weakly associated with non-ICU hospitalization for COVID-19, but not with ICU hospitalization, after adjustment for other risk factors. Excess mortality was observed in both hospitalized and non-hospitalized COVID-19 cases. These results confirm that severe COVID-19 is related to age, sex, and comorbidity in general. The study provides new evidence that hypertension, asthma, Down syndrome, and residence in a long-term care facility are associated with severe COVID-19.We conducted a nationwide, registry-based study to investigate the importance of 34 potential risk factors for coronavirus disease 2019 (COVID-19) diagnosis, hospitalization (with or without intensive care unit [ICU] admission), and subsequent all-cause mortality. The study population comprised all COVID-19 cases confirmed in Sweden by mid-September 2020 (68,575 non-hospitalized, 2494 ICU hospitalized, and 13,589 non-ICU hospitalized) and 434,081 randomly sampled general-population controls. Older age was the strongest risk factor for hospitalization, although the odds of ICU hospitalization decreased after 60-69 years and, after controlling for other risk factors, the odds of non-ICU hospitalization showed no trend after 40-49 years. Residence in a long-term care facility was associated with non-ICU hospitalization. Male sex and the presence of at least one investigated comorbidity or prescription medication were associated with both ICU and non-ICU hospitalization. Three comorbidities associated with both ICU and non-ICU hospitalization were asthma, hypertension, and Down syndrome. History of cancer was not associated with COVID-19 hospitalization, but cancer in the past year was associated with non-ICU hospitalization, after controlling for other risk factors. Cardiovascular disease was weakly associated with non-ICU hospitalization for COVID-19, but not with ICU hospitalization, after adjustment for other risk factors. Excess mortality was observed in both hospitalized and non-hospitalized COVID-19 cases. These results confirm that severe COVID-19 is related to age, sex, and comorbidity in general. The study provides new evidence that hypertension, asthma, Down syndrome, and residence in a long-term care facility are associated with severe COVID-19. We conducted a nationwide, registry-based study to investigate the importance of 34 potential risk factors for coronavirus disease 2019 (COVID-19) diagnosis, hospitalization (with or without intensive care unit [ICU] admission), and subsequent all-cause mortality. The study population comprised all COVID-19 cases confirmed in Sweden by mid-September 2020 (68,575 non-hospitalized, 2494 ICU hospitalized, and 13,589 non-ICU hospitalized) and 434,081 randomly sampled general-population controls. Older age was the strongest risk factor for hospitalization, although the odds of ICU hospitalization decreased after 60–69 years and, after controlling for other risk factors, the odds of non-ICU hospitalization showed no trend after 40–49 years. Residence in a long-term care facility was associated with non-ICU hospitalization. Male sex and the presence of at least one investigated comorbidity or prescription medication were associated with both ICU and non-ICU hospitalization. Three comorbidities associated with both ICU and non-ICU hospitalization were asthma, hypertension, and Down syndrome. History of cancer was not associated with COVID-19 hospitalization, but cancer in the past year was associated with non-ICU hospitalization, after controlling for other risk factors. Cardiovascular disease was weakly associated with non-ICU hospitalization for COVID-19, but not with ICU hospitalization, after adjustment for other risk factors. Excess mortality was observed in both hospitalized and non-hospitalized COVID-19 cases. These results confirm that severe COVID-19 is related to age, sex, and comorbidity in general. The study provides new evidence that hypertension, asthma, Down syndrome, and residence in a long-term care facility are associated with severe COVID-19. We conducted a nationwide, registry-based study to investigate the importance of 34 potential risk factors for coronavirus disease 2019 (COVID-19) diagnosis, hospitalization (with or without intensive care unit [ICU] admission), and subsequent all-cause mortality. The study population comprised all COVID-19 cases confirmed in Sweden by mid-September 2020 (68,575 non-hospitalized, 2494 ICU hospitalized, and 13,589 non-ICU hospitalized) and 434,081 randomly sampled generalpopulation controls. Older age was the strongest risk factor for hospitalization, although the odds of ICU hospitalization decreased after 60–69 years and, after controlling for other risk factors, the odds of non-ICU hospitalization showed no trend after 40–49 years. Residence in a long-term care facility was associated with non-ICU hospitalization. Male sex and the presence of at least one investigated comorbidity or prescription medication were associated with both ICU and non-ICU hospitalization. Three comorbidities associated with both ICU and non-ICU hospitalization were asthma, hypertension, and Down syndrome. History of cancer was not associated with COVID-19 hospitalization, but cancer in the past year was associated with non-ICU hospitalization, after controlling for other risk factors. Cardiovascular disease was weakly associated with non-ICU hospitalization for COVID-19, but not with ICU hospitalization, after adjustment for other risk factors. Excess mortality was observed in both hospitalized and non-hospitalized COVID-19 cases. These results confirm that severe COVID-19 is related to age, sex, and comorbidity in general. The study provides new evidence that hypertension, asthma, Down syndrome, and residence in a long-term care facility are associated with severe COVID-19. |
| Author | Ballin, Marcel Nordström, Peter Nordström, Anna Bergman, Jonathan |
| Author_xml | – sequence: 1 givenname: Jonathan surname: Bergman fullname: Bergman, Jonathan – sequence: 2 givenname: Marcel surname: Ballin fullname: Ballin, Marcel – sequence: 3 givenname: Anna surname: Nordström fullname: Nordström, Anna – sequence: 4 givenname: Peter surname: Nordström fullname: Nordström, Peter |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33704634$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-181835$$DView record from Swedish Publication Index (Umeå universitet) |
| BookMark | eNp9kktP3DAUha2Kqgy0f6BSK0vdsMDUjh-xN5XQQFskJKQ-2FpO4gyeJvbUTjqCX4-HDBRYsLIsf-fe43vPHtjxwVsA3hN8RDAuPyeCBWcIFwTlKy3Q-hWYEV5SVBaS7YAZpoqiQim8C_ZSWmKMJVb8DdiltMRMUDYD1Q-X_sDW1EOICbYhwvnF5dkJIgo2zix8SC4dwquQVm4wnbsxgwv-EBrfwDRWyf4drR-g6TpUmzFZ2Ie44YZr6Dz8ubaN9W_B69Z0yb7bnvvg99fTX_Pv6Pzi29n8-BzVnLIBtYo1hFJuZGFUJQ1pJS0Yw0YIZi0VhZKtlLJVjSFGNFVV4VYp3ghJqMIVofsATXXT2q7GSq-i60281sE4feIuj3WICz32oyaSSMoz_2XiM9zbps4fiaZ7Inv64t2VXoR_ulRMCKJygYNtgRjyHNKge5dq23XG2zAmXXCMacn5Xa9Pz9BlGKPP49hQeUOclTRTHx87erByv64MyAmoY0gp2lbXeS2blWSDrtME600y9JQMnZOh75Kh11laPJPeV39RRLcjzbBf2Pjf9ouqD5NqmXKqHvowWQrGuKK3WnTVcw |
| CitedBy_id | crossref_primary_10_1007_s10238_022_00840_1 crossref_primary_10_1016_j_jamda_2024_105047 crossref_primary_10_1016_j_rmed_2023_107373 crossref_primary_10_1016_S0140_6736_22_00089_7 crossref_primary_10_2500_aap_2023_44_220096 crossref_primary_10_1007_s00101_023_01302_3 crossref_primary_10_1016_j_puhe_2023_10_040 crossref_primary_10_1136_bmjopen_2022_069037 crossref_primary_10_1038_s41598_023_35349_4 crossref_primary_10_3390_vaccines12030329 crossref_primary_10_1186_s12889_025_22522_9 crossref_primary_10_1002_hsr2_1692 crossref_primary_10_1016_j_clnu_2021_07_025 crossref_primary_10_1016_j_intimp_2021_107894 crossref_primary_10_1371_journal_pone_0265812 crossref_primary_10_3389_fimmu_2022_864838 crossref_primary_10_1016_j_jtct_2022_03_010 crossref_primary_10_1016_j_cegh_2023_101494 crossref_primary_10_1136_bmjgh_2021_006247 crossref_primary_10_1001_jamainternmed_2021_5814 crossref_primary_10_1080_20477724_2023_2191232 crossref_primary_10_1186_s12889_022_14448_3 crossref_primary_10_1371_journal_pone_0294556 crossref_primary_10_1038_s41598_021_99561_w crossref_primary_10_1111_pai_13851 crossref_primary_10_1016_j_lanwpc_2022_100487 crossref_primary_10_1371_journal_pone_0256917 crossref_primary_10_3390_v14112340 crossref_primary_10_1016_S1473_3099_22_00143_8 crossref_primary_10_1007_s12020_021_02734_w crossref_primary_10_1016_j_jaci_2024_10_013 crossref_primary_10_1177_10815589231191813 crossref_primary_10_1590_1516_3180_2023_0015_r1_230523 crossref_primary_10_3389_fpubh_2024_1323481 crossref_primary_10_1016_j_jamda_2021_06_010 crossref_primary_10_1111_imj_16276 crossref_primary_10_3389_ijph_2022_1604542 crossref_primary_10_1007_s00432_022_04191_y crossref_primary_10_1177_08850666241268437 crossref_primary_10_1038_s41598_024_52656_6 crossref_primary_10_1001_jamanetworkopen_2022_34319 crossref_primary_10_1038_s41598_025_94765_w crossref_primary_10_1186_s12933_022_01719_x crossref_primary_10_1007_s10489_021_02743_2 crossref_primary_10_3390_v16071025 crossref_primary_10_2147_JIR_S456440 crossref_primary_10_1183_13993003_01209_2021 crossref_primary_10_3390_jcm10122608 crossref_primary_10_3390_medicina60050770 crossref_primary_10_3390_su141912189 crossref_primary_10_1093_intimm_dxab107 crossref_primary_10_3389_fpubh_2022_1076627 crossref_primary_10_3389_fcvm_2024_1279890 crossref_primary_10_1097_CCE_0000000000000705 crossref_primary_10_1186_s12966_021_01198_5 crossref_primary_10_1111_joim_13522 crossref_primary_10_4178_epih_e2024038 crossref_primary_10_1177_03000605241281907 crossref_primary_10_5495_wjcid_v13_i4_37 crossref_primary_10_1371_journal_pone_0286142 crossref_primary_10_4037_ajcc2024898 crossref_primary_10_1038_s41598_022_07138_y crossref_primary_10_1016_j_jaip_2021_10_069 crossref_primary_10_1186_s12890_023_02761_5 crossref_primary_10_3390_medicina61010121 crossref_primary_10_1183_13993003_04474_2020 crossref_primary_10_1136_jech_2021_218278 crossref_primary_10_1038_s41366_021_00943_x crossref_primary_10_1093_eurpub_ckad016 crossref_primary_10_1093_ndt_gfad151 crossref_primary_10_1007_s00101_023_01336_7 crossref_primary_10_5812_ijpr_127032 crossref_primary_10_1080_15287394_2023_2223598 crossref_primary_10_1186_s12890_024_03468_x crossref_primary_10_1007_s10198_024_01680_4 crossref_primary_10_1016_j_puhe_2022_07_014 crossref_primary_10_3390_ijerph191711093 crossref_primary_10_1016_j_rmed_2022_107088 crossref_primary_10_4103_jhrs_jhrs_78_21 crossref_primary_10_1055_a_2414_8447 crossref_primary_10_1016_j_ijcha_2024_101574 crossref_primary_10_1016_j_jaut_2021_102687 crossref_primary_10_1001_jamanetworkopen_2023_55808 crossref_primary_10_1093_occmed_kqad114 crossref_primary_10_1155_2022_3098527 crossref_primary_10_3201_eid2901_220530 crossref_primary_10_1136_bmjopen_2023_075028 crossref_primary_10_1183_23120541_00711_2022 crossref_primary_10_1097_CCE_0000000000000876 crossref_primary_10_1186_s12889_024_17904_4 crossref_primary_10_3389_fpubh_2022_921953 crossref_primary_10_1177_13623613231160631 crossref_primary_10_1186_s12875_023_02228_w crossref_primary_10_1016_j_puhe_2023_06_032 |
| Cites_doi | 10.1136/bmj.m1966 10.1001/jama.2020.1097 10.1056/NEJMoa2006923 10.1016/S0140-6736(20)31199-5 10.1002/pds.1294 10.1001/jamacardio.2020.1855 10.1080/02841860802247664 10.1097/MD.0000000000023327 10.1038/s41586-020-2521-4 10.1093/ije/dyaa140 10.1016/S2213-8587(20)30272-2 10.1016/j.jinf.2020.04.021 10.1001/jama.2020.11301 10.1007/s10654-017-0316-1 10.1001/jama.2020.25864 10.1016/S0140-6736(20)31189-2 10.1136/bmj.m1985 10.1126/science.abb6105 10.1186/1471-2458-11-450 10.1056/NEJMoa2002032 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2021 – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7T2 7TK 7TS 7U7 7U9 7X7 7XB 88C 88E 8AO 8C1 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 K9. M0S M0T M1P M2O MBDVC PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7X8 5PM ADHXS ADTPV AOWAS D8T D93 ZZAVC |
| DOI | 10.1007/s10654-021-00732-w |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Health and Safety Science Abstracts (Full archive) Neurosciences Abstracts Physical Education Index Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Healthcare Administration Database Medical Database Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) SWEPUB Umeå universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Umeå universitet SwePub Articles full text |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection Physical Education Index Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Central Basic Toxicology Abstracts ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Research Library Prep CrossRef MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: M0T name: Healthcare Administration Database url: https://search.proquest.com/healthmanagement sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1573-7284 |
| EndPage | 298 |
| ExternalDocumentID | oai_DiVA_org_umu_181835 PMC7946619 33704634 10_1007_s10654_021_00732_w 48764459 |
| Genre | Journal Article |
| GeographicLocations | Sweden |
| GeographicLocations_xml | – name: Sweden |
| GrantInformation_xml | – fundername: Umea University – fundername: ; |
| GroupedDBID | --- -~C .86 .VR 06C 06D 0R~ 0VY 199 1N0 203 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 4.4 406 408 409 40D 40E 5GY 5VS 67Z 6NX 78A 7X7 88E 8AO 8C1 8FI 8FJ 8G5 8TC 8UJ 95- 95. 95~ 96X A8Z AAAVM AABHQ AACDK AACGO AAHNG AAIAL AAJBT AAJKR AANCE AANZL AAPKM AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYZH ABAKF ABBBX ABBHK ABBRH ABBXA ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABPLY ABQBU ABSXP ABTEG ABTKH ABTLG ABTMW ABUWG ABWNU ABXPI ACAOD ACDTI ACGFO ACGFS ACHSB ACHXU ACIHN ACKNC ACMDZ ACMFV ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACSTC ACZOJ ADBBV ADHHG ADHIR ADIMF ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEAQA AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEUPB AEUYN AEVLU AEXYK AEXZC AEZWR AFBBN AFDZB AFHIU AFKRA AFLOW AFOHR AFQWF AFRAH AFWTZ AFYQB AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG AQUVI ARMRJ ASPBG ATHPR AVWKF AXYYD AYFIA AZFZN AZQEC B-. BA0 BENPR BGNMA BPHCQ BSONS BVXVI CCPQU CS3 CSCUP DCCCD DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EMB EMOBN EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FNLPD FRRFC FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ7 GQ8 GUQSH GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF I09 I5X IHE IJ- IKXTQ IMOTQ IPSME ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JENOY JLS JPM JSG JST JZLTJ KDC KOV KPH LAK LLZTM M0T M1P M2O M4Y MA- NB0 NPVJJ NQJWS NU0 O93 O9G O9I O9J OAM P19 P2P P9S PF0 PHGZM PHGZT PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV ROL RPX RRX RSV S16 S27 S37 S3B SA0 SAP SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 ZMTXR ZOVNA ~EX -53 -5E -5G -BR -EM -Y2 1SB 2.D 28- 2P1 2VQ 3SX 3V. 53G 5QI AANXM AARHV AAYTO ABQSL ABULA ABXSQ ACBXY ACHIC ACUDM ADINQ ADULT AEBTG AEFIE AEKMD AFEXP AGGDS AJBLW AQVQM BBWZM BDATZ C6C CAG COF DOOOF EJD EN4 FINBP FSGXE GQ6 GRRUI H13 HGD HQ3 HTVGU HZ~ JAAYA JBMMH JHFFW JKQEH JLXEF JSODD KOW LAS N2Q NDZJH O9- OVD R4E RNI RZC RZE RZK S1Z S26 S28 SCLPG SDE T16 TEORI WK6 Z7U Z7W Z81 Z82 Z83 Z87 Z8O Z8Q Z8U Z8V Z8W Z91 ZXP AAYXX ABRTQ ADHKG ADQXQ AFFHD AGQPQ CITATION PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7QL 7T2 7TK 7TS 7U7 7U9 7XB 8FK C1K ESTFP H94 K9. MBDVC PKEHL PQEST PQUKI Q9U 7X8 PUEGO 5PM ADHXS ADTPV AOWAS D8T D93 ZZAVC |
| ID | FETCH-LOGICAL-c534t-f94d1335a82a9b8a1f832440a664ee36298f888f9da1a6dbbb0f995d681390b13 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 110 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000627668800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0393-2990 1573-7284 |
| IngestDate | Tue Nov 04 16:54:07 EST 2025 Tue Nov 04 01:58:44 EST 2025 Thu Oct 02 05:56:40 EDT 2025 Tue Dec 02 16:04:23 EST 2025 Mon Jul 21 05:34:23 EDT 2025 Tue Nov 18 22:12:49 EST 2025 Sat Nov 29 04:31:25 EST 2025 Fri Feb 21 02:48:35 EST 2025 Thu Jun 19 20:12:36 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | COVID-19 SARS-CoV-2 Coronavirus Case–control study Epidemiology Cohort study |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c534t-f94d1335a82a9b8a1f832440a664ee36298f888f9da1a6dbbb0f995d681390b13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-9638-7208 0000-0003-2924-508X 0000-0003-1904-6140 0000-0003-3534-456X |
| OpenAccessLink | https://link.springer.com/10.1007/s10654-021-00732-w |
| PMID | 33704634 |
| PQID | 2509905473 |
| PQPubID | 33638 |
| PageCount | 12 |
| ParticipantIDs | swepub_primary_oai_DiVA_org_umu_181835 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7946619 proquest_miscellaneous_2500375535 proquest_journals_2509905473 pubmed_primary_33704634 crossref_citationtrail_10_1007_s10654_021_00732_w crossref_primary_10_1007_s10654_021_00732_w springer_journals_10_1007_s10654_021_00732_w jstor_primary_48764459 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-03-01 |
| PublicationDateYYYYMMDD | 2021-03-01 |
| PublicationDate_xml | – month: 03 year: 2021 text: 2021-03-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Dordrecht |
| PublicationPlace_xml | – name: Dordrecht – name: Netherlands |
| PublicationTitle | European journal of epidemiology |
| PublicationTitleAbbrev | Eur J Epidemiol |
| PublicationTitleAlternate | Eur J Epidemiol |
| PublicationYear | 2021 |
| Publisher | Springer Science + Business Media Springer Netherlands Springer Nature B.V |
| Publisher_xml | – name: Springer Science + Business Media – name: Springer Netherlands – name: Springer Nature B.V |
| References | Wettermark, Hammar, MichaelFored (CR16) 2007; 16 Bae, Kim, Kim (CR26) 2020; 5 CR19 Fosbøl, Butt, Østergaard (CR11) 2020; 324 CR18 Tian, Liu, Li (CR3) 2020; 368 CR17 Barron, Bakhai, Kar (CR12) 2020; 8 CR31 CR30 Petrilli, Jones, Yang (CR6) 2020; 369 Williamson, Walker, Bhaskaran (CR7) 2020; 584 Clift, Coupland, Keogh (CR20) 2020; 21 Mehta, Kalra, Nowacki (CR22) 2020; 5 Phelan, Katz, Gostin (CR1) 2020; 323 Docherty, Harrison, Green (CR4) 2020; 369 Ludvigsson, Andersson, Ekbom (CR14) 2011; 11 Zheng, Peng, Xu (CR27) 2020; 81 Mancia, Rea, Ludergnani (CR21) 2020; 382 Reilev, Kristensen, Pottegård (CR8) 2020; 49 CR2 Guan, Ni, Hu (CR10) 2020; 382 Cohen, Hanff, William (CR23) 2021; S2213–2600 CR29 Lopes, Macedo, de Barros, Silva (CR24) 2021; 325 Kim, Garg, O’Halloran (CR5) 2020; 2 Barlow, Westergren, Holmberg (CR15) 2009; 48 Brooke, Talbäck, Hörnblad (CR13) 2017; 32 Burki (CR28) 2020; 395 Cummings, Baldwin, Abrams (CR9) 2020; 395 Wang, Deng, Ou (CR25) 2020; 99 L Barlow (732_CR15) 2009; 48 A Clift (732_CR20) 2020; 21 732_CR19 CM Petrilli (732_CR6) 2020; 369 Z Zheng (732_CR27) 2020; 81 732_CR2 MJ Cummings (732_CR9) 2020; 395 732_CR29 EL Fosbøl (732_CR11) 2020; 324 W Guan (732_CR10) 2020; 382 L Kim (732_CR5) 2020; 2 S Bae (732_CR26) 2020; 5 JB Cohen (732_CR23) 2021; S2213–2600 T Burki (732_CR28) 2020; 395 G Mancia (732_CR21) 2020; 382 HL Brooke (732_CR13) 2017; 32 M Reilev (732_CR8) 2020; 49 AB Docherty (732_CR4) 2020; 369 B Wettermark (732_CR16) 2007; 16 N Mehta (732_CR22) 2020; 5 Z Wang (732_CR25) 2020; 99 AL Phelan (732_CR1) 2020; 323 H Tian (732_CR3) 2020; 368 732_CR18 732_CR17 JF Ludvigsson (732_CR14) 2011; 11 RD Lopes (732_CR24) 2021; 325 E Barron (732_CR12) 2020; 8 732_CR31 EJ Williamson (732_CR7) 2020; 584 732_CR30 |
| References_xml | – volume: 369 start-page: m1966 year: 2020 ident: CR6 article-title: Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study publication-title: BMJ doi: 10.1136/bmj.m1966 – volume: 323 start-page: 709 year: 2020 end-page: 710 ident: CR1 article-title: The novel coronavirus originating in Wuhan, China: challenges for global health governance publication-title: JAMA doi: 10.1001/jama.2020.1097 – volume: 382 start-page: 2431 year: 2020 end-page: 2440 ident: CR21 article-title: Renin–angiotensin–aldosterone system blockers and the risk of COVID-19 publication-title: N Engl J Med doi: 10.1056/NEJMoa2006923 – ident: CR18 – volume: 395 start-page: 1602 year: 2020 ident: CR28 article-title: England and Wales see 20 000 excess deaths in care homes publication-title: Lancet doi: 10.1016/S0140-6736(20)31199-5 – volume: S2213–2600 start-page: 30558 issue: 20 year: 2021 ident: CR23 article-title: Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial publication-title: Lancet Respir Med – ident: CR2 – ident: CR30 – volume: 16 start-page: 726 year: 2007 end-page: 735 ident: CR16 article-title: The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.1294 – ident: CR29 – volume: 5 start-page: 1020 year: 2020 end-page: 1026 ident: CR22 article-title: Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19) publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2020.1855 – volume: 48 start-page: 27 year: 2009 end-page: 33 ident: CR15 article-title: The completeness of the Swedish Cancer Register-a sample survey for year 1998 publication-title: Acta Oncol (Madr) doi: 10.1080/02841860802247664 – volume: 5 start-page: 1 year: 2020 end-page: 8 ident: CR26 article-title: Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis publication-title: Heart – ident: CR19 – volume: 99 start-page: e23327 year: 2020 ident: CR25 article-title: Clinical symptoms, comorbidities and complications in severe and non-severe patients with COVID-19: a systematic review and meta-analysis without cases duplication publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000023327 – volume: 2 start-page: 16 year: 2020 ident: CR5 article-title: Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) publication-title: Clin Infect Dis – volume: 584 start-page: 430 year: 2020 end-page: 436 ident: CR7 article-title: Factors associated with COVID-19-related death using OpenSAFELY publication-title: Nature doi: 10.1038/s41586-020-2521-4 – volume: 49 start-page: 1468 year: 2020 end-page: 1481 ident: CR8 article-title: Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort publication-title: Int J Epidemiol doi: 10.1093/ije/dyaa140 – volume: 8 start-page: 813 year: 2020 end-page: 822 ident: CR12 article-title: Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(20)30272-2 – ident: CR17 – ident: CR31 – volume: 81 start-page: e16 year: 2020 end-page: 25 ident: CR27 article-title: Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis publication-title: J Infect doi: 10.1016/j.jinf.2020.04.021 – volume: 324 start-page: 168 year: 2020 end-page: 177 ident: CR11 article-title: Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality publication-title: JAMA doi: 10.1001/jama.2020.11301 – volume: 32 start-page: 765 year: 2017 end-page: 773 ident: CR13 article-title: The Swedish cause of death register publication-title: Eur J Epidemiol doi: 10.1007/s10654-017-0316-1 – volume: 325 start-page: 254 year: 2021 end-page: 264 ident: CR24 article-title: Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2020.25864 – volume: 395 start-page: 1763 year: 2020 end-page: 1770 ident: CR9 article-title: Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study publication-title: Lancet doi: 10.1016/S0140-6736(20)31189-2 – volume: 369 start-page: m1985 year: 2020 ident: CR4 article-title: Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study publication-title: BMJ doi: 10.1136/bmj.m1985 – volume: 368 start-page: 638 year: 2020 end-page: 642 ident: CR3 article-title: An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China publication-title: Science doi: 10.1126/science.abb6105 – volume: 21 start-page: 20 year: 2020 end-page: 4986 ident: CR20 article-title: COVID-19 mortality risk in Down syndrome: results from a cohort study of 8 million adults publication-title: Ann Intern Med – volume: 11 start-page: 450 year: 2011 ident: CR14 article-title: External review and validation of the Swedish national inpatient register publication-title: BMC Public Health doi: 10.1186/1471-2458-11-450 – volume: 382 start-page: 1708 year: 2020 end-page: 1720 ident: CR10 article-title: Clinical characteristics of coronavirus disease 2019 in China publication-title: N Engl J Med doi: 10.1056/NEJMoa2002032 – volume: 323 start-page: 709 year: 2020 ident: 732_CR1 publication-title: JAMA doi: 10.1001/jama.2020.1097 – ident: 732_CR31 – volume: 81 start-page: e16 year: 2020 ident: 732_CR27 publication-title: J Infect doi: 10.1016/j.jinf.2020.04.021 – ident: 732_CR29 – volume: 382 start-page: 1708 year: 2020 ident: 732_CR10 publication-title: N Engl J Med doi: 10.1056/NEJMoa2002032 – volume: S2213–2600 start-page: 30558 issue: 20 year: 2021 ident: 732_CR23 publication-title: Lancet Respir Med – volume: 48 start-page: 27 year: 2009 ident: 732_CR15 publication-title: Acta Oncol (Madr) doi: 10.1080/02841860802247664 – ident: 732_CR2 – volume: 2 start-page: 16 year: 2020 ident: 732_CR5 publication-title: Clin Infect Dis – volume: 584 start-page: 430 year: 2020 ident: 732_CR7 publication-title: Nature doi: 10.1038/s41586-020-2521-4 – volume: 369 start-page: m1985 year: 2020 ident: 732_CR4 publication-title: BMJ doi: 10.1136/bmj.m1985 – volume: 382 start-page: 2431 year: 2020 ident: 732_CR21 publication-title: N Engl J Med doi: 10.1056/NEJMoa2006923 – ident: 732_CR18 – volume: 16 start-page: 726 year: 2007 ident: 732_CR16 publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.1294 – volume: 99 start-page: e23327 year: 2020 ident: 732_CR25 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000023327 – volume: 8 start-page: 813 year: 2020 ident: 732_CR12 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(20)30272-2 – volume: 49 start-page: 1468 year: 2020 ident: 732_CR8 publication-title: Int J Epidemiol doi: 10.1093/ije/dyaa140 – volume: 395 start-page: 1763 year: 2020 ident: 732_CR9 publication-title: Lancet doi: 10.1016/S0140-6736(20)31189-2 – volume: 395 start-page: 1602 year: 2020 ident: 732_CR28 publication-title: Lancet doi: 10.1016/S0140-6736(20)31199-5 – volume: 324 start-page: 168 year: 2020 ident: 732_CR11 publication-title: JAMA doi: 10.1001/jama.2020.11301 – volume: 11 start-page: 450 year: 2011 ident: 732_CR14 publication-title: BMC Public Health doi: 10.1186/1471-2458-11-450 – volume: 368 start-page: 638 year: 2020 ident: 732_CR3 publication-title: Science doi: 10.1126/science.abb6105 – volume: 5 start-page: 1020 year: 2020 ident: 732_CR22 publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2020.1855 – volume: 369 start-page: m1966 year: 2020 ident: 732_CR6 publication-title: BMJ doi: 10.1136/bmj.m1966 – volume: 5 start-page: 1 year: 2020 ident: 732_CR26 publication-title: Heart – volume: 32 start-page: 765 year: 2017 ident: 732_CR13 publication-title: Eur J Epidemiol doi: 10.1007/s10654-017-0316-1 – volume: 325 start-page: 254 year: 2021 ident: 732_CR24 publication-title: JAMA doi: 10.1001/jama.2020.25864 – ident: 732_CR30 – ident: 732_CR17 – ident: 732_CR19 – volume: 21 start-page: 20 year: 2020 ident: 732_CR20 publication-title: Ann Intern Med |
| SSID | ssj0008095 |
| Score | 2.5962987 |
| Snippet | We conducted a nationwide, registry-based study to investigate the importance of 34 potential risk factors for coronavirus disease 2019 (COVID-19) diagnosis,... |
| SourceID | swepub pubmedcentral proquest pubmed crossref springer jstor |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 287 |
| SubjectTerms | Adolescent Adult Age Factors Aged Aged, 80 and over Asthma Cancer Cardiology Cardiovascular diseases Case–control study Cohort analysis Cohort study Comorbidity Coronavirus Coronaviruses COVID-19 COVID-19 - diagnosis COVID-19 - epidemiology COVID-19 - mortality Diagnosis Down syndrome Down's syndrome Epidemiology Female Hospitalization Hospitalization - statistics & numerical data Humans Hypertension Infectious Diseases Intensive Care Units - statistics & numerical data Long term health care Long-term care Male Medicine Medicine & Public Health Middle Aged Mortality Mortality - trends Oncology Population control Population studies Public Health Residential Facilities - statistics & numerical data Risk analysis Risk Factors Risk management SARS-CoV-2 Sex Sex Factors Socioeconomic Factors Sweden - epidemiology Viral diseases Young Adult |
| Subtitle | a nationwide study |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED9BhxDSxMdgW2AgIyFeqEU-bDfeyzT2IZCgTAOqvVlO7LBoXTqaZv33sR03VQH1hec4ia07n-98d78fwBupC5npOMJJxjQmOWOY81zhvKCKRqxghYNjGH0eDIfpxQU_8xdutS-rXNhEZ6jVJLd35O_NUW0Mp2XKPbj5hS1rlM2uegqNu7BhkcpIDzY-nAzPzjtbnIaOd8U2oGJreH3bjG-eY5RgW6Jg01Uxnq8cTW114r_8zr_LJ7sc6h94o-6MOn30v6t7DA-9d4oOW3V6And0tQX3v_j8-xZstrd8qG1eegq352V9hTxnDzL-Lzr6Ovp0jCOOVFvDV9Z9dOm5SXzLZx_JSqHaWCxXxj1DcjzGuWxqja5dMGACA1RW6NtcG6O4jyRqbyznpdLIweE-gx-nJ9-PPmLP5IBzmpAZLjhRJhimMo0lz1IZFcaQEBJKxojW5gzlaWFC8YIrGUmmsiwLC86pYqlxUMMsSrahV00qvQuISKpjGesolMb5yzOZMqqSJJQktVzuLIBoIUSRe5hzy7YxFkuAZit4YQQvnODFPIB33Ts3LcjH2tHbTje6oSbmM14l5QHsLYQrvCWoxVKyAbzuHps9bBMzstKTxo2xVMQ0oQHstLrVfTxJBhbUjQQwWNG6boDFB199UpWXDifccQdEZlr9hX4up7VueW9bHV75w3E5OhST6U_RXDfCeIXGcX--frkv4EHsNpet19uD3mza6JdwL7-dlfX0ld-ovwH7wkRk priority: 102 providerName: ProQuest |
| Title | Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden |
| URI | https://www.jstor.org/stable/48764459 https://link.springer.com/article/10.1007/s10654-021-00732-w https://www.ncbi.nlm.nih.gov/pubmed/33704634 https://www.proquest.com/docview/2509905473 https://www.proquest.com/docview/2500375535 https://pubmed.ncbi.nlm.nih.gov/PMC7946619 https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-181835 |
| Volume | 36 |
| WOSCitedRecordID | wos000627668800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1573-7284 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0008095 issn: 1573-7284 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD5iG0JIiMvYWGBURkK8UEu52bV5G90mkFg3daPqW-QkDovo0qlp1r_PsXMZhWkSvFiq4rqJ-_n4c8453wF4r3SmYu17NIi5pmHCOZUySWmSsZR5POOZlWOYfBuMRmI6lWdNUljZRru3LklrqX9LduMspCakwLiXfLragC3c7oRZjuPzSWd_hWtrrZikU2qMbZMqc_cYa9tRHZF4F9f8O2Sy85v-oTFq96XjZ__3RM_hacNDyUENnBfwQBfb8Oik8bRvw5P6fR6p05Rews04L3-SpjoPQaZLhqeTr4fUkySto_Xysk8umyokTXJnn6giJSXaJhuwvSRqNqOJqkpNriztxyMAyQtyvtJo_j4RRep3k6s81cQK3-7A9-Oji-EX2tRsoAkLwiXNZJjisZcp4SsZC-VlaDLC0FWch1rjbilFhofuTKbKUzyN49jNpGQpF0hF3dgLdmGzmBd6D0iomPaVrz1XIc1LYiU4S4PAVaEwVdu5A17710VJI2hu6mrMolspZjPBEU5wZCc4WjnwsfvOdS3ncW_vXYuIriue7pA_MunAfguRqFnzZYRkEtFmajk78K67jKvVuGBUoeeV7WOKDrOAOfCqRlQ3eBAMjHxb6MBgDWtdB6MEvn6lyC-tIritEuDhbfVboN3e1n2P96FG7tovHOaTg2i--BFVV1WE_A8p-ut_G_cNPPYtqE2k3j5sLheVfgsPk5tlXi56sDGYDmwrsBVDrwdbn49GZ2P8dOJemNY_7dkl_QuxIT_P |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3bbhMxEB2VgigS4lJaWChgJOCFWOzNzhoJoaqhatQkIAhR34x37aUr0k3JJo34Kb4R23uJAihvfeB5vfczxzP2zByA50KlIla-h4OYKhwmlGLGEomTlEji0ZSmth3DqNceDKKTE_ZxA37VtTAmrbLmREvUcpKYNfLXeqrWxGmUct-d_8BGNcrsrtYSGiUsjtXPhQ7Zirfdjv6_L3z_8P3w4AhXqgI4IUE4wykLpQ7MiIh8weJIeKkGdRi6gtJQKc3nLEp1WJgyKTxBZRzHbsoYkTTSzpIbe4G-7hW4avrqmRTCvjtsmD9yrcqLKXfFhuarIp2qVI-SEJuECLM55uPFykRY5kL-y8v9O1mz2bH9o7upnREPb_9v3_IO3Kp8b7RfGstd2FD5NlzvV9kF23CzXMNEZWnWPbj4lBXfUaVIhLR3jw4-jLod7DEkywzFrGih00p5pSpobSGRS1RoPrZJ6jMkxmOciHmh0JkNdXTYg7IcfV4oTflvkEDleuwikwrZZr878OVSvsIubOaTXD0AFAqifOErzxXatU1iEVEig8AVYWSU6qkDXg0anlRN3I2WyJgv208boHENNG6BxhcOvGrOOS9bmKwdvWux2AzVEa32mQlzYK8GE694ruBLJDnwrDmsGcpsO4lcTeZ2jBFaJgFx4H6J5ebiQdA2LetCB9orKG8GmO7nq0fy7NR2QbfKCJ5-rFZtD8vHWvd6L0ubWblDJxvt88n0G5-fzbn2eXVY8nD96z6FraNhv8d73cHxI7jhW8M2mYl7sDmbztVjuJZczLJi-sRSBIKvl21HvwH3DZ7J |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3bbtNAEB2VgiokxKVQMBRYJOCFrOrbbrxICFUJEVFLqKBEfTNre00tUqfESS1-ja9jdn2JAihvfeDZ6_uZ2ZndM3MAnkuVyki5DvUirqgfc06FiBMapyxhDk95atoxjA-7o1FwciKONuBXUwujaZWNTzSOOpnGeo18D6dqdJxaKXcvrWkRR_3B2_MfVCtI6Z3WRk6jgsiB-lli-la8GfbxX79w3cG74957WisM0Jh5_pymwk8wSWMycKWIAumkCHDftyXnvlLo20WQYoqYikQ6kidRFNmpECzhAQZOduR4eN0rcLXrIYp1lXpvSS8JbKP4oktfqXb5dcFOXbbHmU81OUJvlLm0XJkUK17kvyLev4mb7e7tH51Ozew4uPU_f9fbcLOOycl-ZUR3YEPl27D1oWYdbMONam2TVCVbd-HiU1Z8J7VSEcGon_Q-jod96giSVMzFrOiQ01qRpS507RCZJ6RAP23I63MiJxMay0WhyJlJgTAdIllOPpcKp4LXRJJqnbbMEkVME-B78OVSvsIObObTXD0A4kumXOkqx5YY8saRDDhLPM-WfqAV7LkFTgOgMK6bu2uNkUm4bEutQRci6EIDurC04FV7znnV2mTt6B2Dy3YoZroYSzNhwW4DrLD2f0W4RJUFz9rD6Ln0dpTM1XRhxmgBZuYxC-5XuG4v7nld3crOt6C7gvh2gO6Kvnokz05Nd3SjmODgY3Ua21g-1rrXe1nZz8od-tl4P5zOvoWLs0WIsTCmKw_Xv-5T2ELzCQ-Ho4NHcN01Nq4Ji7uwOZ8t1GO4Fl_Ms2L2xHgLAl8v24x-A42Kp0c |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Risk+factors+for+COVID-19+diagnosis%2C+hospitalization%2C+and+subsequent+all-cause+mortality+in+Sweden&rft.jtitle=European+journal+of+epidemiology&rft.au=Bergman%2C+Jonathan&rft.au=Ballin%2C+Marcel&rft.au=Nordstr%C3%B6m%2C+Anna&rft.au=Nordstr%C3%B6m%2C+Peter&rft.date=2021-03-01&rft.issn=1573-7284&rft.volume=36&rft.issue=3&rft.spage=287&rft_id=info:doi/10.1007%2Fs10654-021-00732-w&rft.externalDocID=oai_DiVA_org_umu_181835 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0393-2990&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0393-2990&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0393-2990&client=summon |